Corticosterone triggers endocannabinoid production in a key pain-processing brain region, reducing inhibitory GABA signaling through CB1 receptors and potentially activating the body's pain-suppression pathway.
Neuroscience enthusiasts; researchers studying pain and endocannabinoid mechanisms
Corticosterone promoted 2-AG synthesis via a distinct Gs/PKA pathway in the pain-modulating vlPAG
What the researchers found
In the ventrolateral periaqueductal gray (vlPAG), corticosterone activates putative membrane-bound glucocorticoid receptors, which stimulate 2-AG synthesis. This 2-AG then activates presynaptic CB1 receptors to reduce GABA release.
Why it matters
This study maps a specific molecular mechanism linking stress to pain modulation via the endocannabinoid system.
The numbers in context
Corticosterone-mediated signaling enhanced 2-AG synthesis that was blocked by the DAGL inhibitor DO34. The effect was dependent on a Gs-protein and protein kinase A pathway.
How the study worked
Electrophysiology experiments in rodent brain slices. Researchers used pharmacological manipulations including CB1 receptor antagonists, diacylglycerol lipase inhibitors, and protein kinase A blockers.
What this study cannot tell us
In vitro brain slice preparation removes the circuit from its natural context. Uses rodent tissue. The glucocorticoid receptors are described as "putative."
How to read the evidence
Well-designed mechanistic study using multiple pharmacological controls in brain slices; moderate because it establishes clear mechanism but in vitro only.
When this study was published
2025 study with current electrophysiology methods
The bigger picture
The vlPAG is a critical hub in descending pain control. This work shows that stress hormones and endocannabinoids interact at this hub in specific, pathway-dependent ways.
Questions still open
- Could targeting this specific pathway offer pain relief without the side effects of systemic cannabinoid administration?
Common questions
What is the vlPAG and why does it matter for pain?
What is 2-AG?
Read the original research
Corticosterone stimulates synthesis of 2-arachidonoylglycerol via putative membrane-bound glucocorticoid receptors and inhibits GABA release via CB1 cannabinoid receptors in the ventrolateral periaqueductal gray.
Molecular pharmacology, 107(8), 100058
Citation
Coutens, Basile; Bouchet, Courtney A; Patti, Lorenzo C; McPherson, Kylie B; Boston, Bethany S; Jewett, David C; Ingram, Susan L. (2025). Corticosterone stimulates synthesis of 2-arachidonoylglycerol via putative membrane-bound glucocorticoid receptors and inhibits GABA release via CB1 cannabinoid receptors in the ventrolateral periaqueductal gray.. Molecular pharmacology, 107(8), 100058. https://doi.org/10.1016/j.molpha.2025.100058
Explore the wider topic
- How THC Affects Your Amygdala: The Brain's Threat Detector and Cannabis
- The Anandamide Connection: Your Body's Natural Bliss Molecule
- How Long for Cannabinoid Receptors to Return to Normal
- Cannabis and the Developing Brain: What Every Teenager (and Parent) Should Know
- Why Can't I Enjoy Anything Without Weed? The Science Behind It
- Dopamine Recovery After Quitting Weed: What the Science Says
- The Endocannabinoid System Explained Simply: What It Does and Why It Matters
- Your Endocannabinoid System Explained: Why Withdrawal Happens
- Your Nervous System After Quitting Weed: Fight or Flight
- Using Weed Under 18: What It Does to Your Developing Brain
- What THC Does to Your Brain: Why Withdrawal Happens
- THC and Your Prefrontal Cortex: What Cannabis Does to Your Decision-Making Brain
- Weed, Cortisol, and Stress: What Cannabis Does to Your Stress Hormones
- Weed and Memory: What the Science Says About THC and Your Hippocampus
- Weed and Motivation: Is Amotivational Syndrome Real?
- Weed and Your Nervous System: What THC Actually Does to Your Brain and Body
- How Weed Rewires Your Reward System (And How to Reset It)